QCL-104766 (060-101)

• Research type

  Research Study

• Full title

  A PHASE 1, OPEN LABEL, TWO PERIOD, NON RANDOMIZED STUDY ASSESSING NASAL AND PULMONARY DEPOSITION OF A SINGLE DOSE OF CICLESONIDE FOLLOWING NASAL INHALATION OF A NOVEL NASAL HYDROFLUOROALKANE (HFA) METERED DOSE INHALER (MDI) AND OF AN AQUEOUS (AQ) NASAL SPRAY

• IRAS ID

  53803

• Contact name

  Joanne Collier

• Sponsor organisation

  Sepracor Inc.

• Eudract number

  2010-020107-76

• Research summary

  The purpose of the study is to look at how Ciclesonide spreads through the nose and airways by a new nasal spray.The study will also look at how Omnareas© spreads through the nose and airways. Omnareas© is a marketed aqueous nasal spray also containing ciclesonide, by Sepracor.

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  10/IEC01/13

• Date of REC Opinion

  5 Jul 2010

• REC opinion

  Further Information Favourable Opinion